Online Journal CME Articles

Vol 30.5: Treatable Causes of Cerebellar Ataxia
Adolfo Ramirez-Zamora, MD; Warren Zeigler, MD; Neeja Desai, MD; and Jose Biller, MD, FACP, FAAN, FANA, FAHA
Author Disclosures: The four authors had no relevant financial information to disclose. A.R.Z. has served as consultant for TEVA neuroscience. W.Z., N.D., and J.B.: Nothing to disclose.
Start date: June 2, 2015
Expiration date: June 2, 2016
 

Vol 30.4: Tourette Syndrome Deep Brain Stimulation: A Review and Updated Recommendations
Lauren E. Schrock, MD; Jonathan W. Mink, MD, PhD; Douglas W. Woods, PhD; Mauro Porta, MD; Dominico Servello, MD; Veerle Visser-Vandewalle, MD, PhD; Peter A. Silburn, MD; Thomas Foltynie, MRCP, PhD; Harrison C. Walker, MD; Joohi Shahed-Jimenez, MD; Rodolfo Savica, MD; Bryan T. Klassen, MD; Andre G. Machado, MD; Kelly D. Foote, MD; Jian-Guo Zhang, MD, PhD; Wei Hu, MD, PhD; Linda Ackermans, MD, PhD; Yasin Temel, MD, PhD; Zoltan Mari, MD; Barbara K. Changizi, MD; Andres Lozano, MD; M. Auyeung, MD; Takanobu Kaido, MD, PhD; Yves Agid, MD, PhD; Marie L. Welter, MD, PhD; Suketu M. Khandhar, MD; Alon Y. Mogilner, MD, PhD;Michael H. Pourfar, MD; Benjamin L. Walter, MD; Jorge L. Juncos, MD; Robert E. Gross, MD; Jens Kuhn, MD;James F. Leckman, MD; Joseph A Neimat, MD; Michael S. Okun, MD * on behalf of the Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group
Author Disclosures: Dr. Okun serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. Dr. Okun has previously received honoraria, but in the past >60 months has received no support from industry. Dr. Okun has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, and Cambridge (movement disorders books). Dr. Okun is an associate editor for New England Journal of Medicine Journal Watch Neurology. Dr. Okun has participated in CME and educational activities on movement disorders (in the last 36) months sponsored by PeerView, Prime, Quantia, Henry Stewart, and by Vanderbilt University. The institution and not Dr. Okun receives grants from Medtronic, Abbvie, and ANS/St. Jude, and the PI has no financial interest in these grants. Dr. Okun has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria.
Start date:
June 2, 2015
Expiration date: June 2, 2016
 

Vol 30.3: Stem Cell Reprogramming: Basic Implications and Future Perspective for Movement Disorders
Björn Brändl, MSc; Susanne A. Schneider, MD, PhD; Jeanne F. Loring, PhD; John Hardy, PhD; Philip Gribbon, PhD; and Franz-Josef Müller, MD
Author Disclosures: The six authors had no relevant financial information to disclose. S.A.S. and F.J.M. are supported by the Else Kröner-Fresenius Stiftung.
Start date: June 2, 2015
Expiration date: June 2, 2016
 

Vol 30.2:  Management of Impulse Control Disorders in Parkinson’s Disease: Controversies and Future Approaches
Michael Samuel, MD, FRCP; Maria Rodriguez-Oroz, MD, PhD; Angelo Antonini, MD, PhD; Jonathan M. Brotchie, PhD; Kallol Ray Chaudhuri, MD, FRCP, DSc; Richard G. Brown, PhD; Wendy R. Galpern, MD, PhD; Melissa J. Nirenberg, MD, PhD; Michael S. Okun, MD; and Anthony E. Lang, MD
Author Disclosures: Samuel M. Conflicts of interest. None. Dr Samuel has received honoraria for educational meetings / travel / accommodation from Medtronic, St Jude Medical, and UCB, grants from Parkinson's UK and Ipsen, and has acted as a consultant for Medtronic and St Jude Medical.
Start date: June 2, 2015
Expiration date: June 2, 2016
 

Vol 30.1: Four Pioneers of L-dopa Treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr
Andrew J. Lees, FRCP, F.Med.Sci., Eduardo Tolosa, MD, and C. Warren Olanow, MD
Author Disclosures: Andrew J Lees is funded by the Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology. He has received grants/research support from the PSP Association, Weston Trust, and the Reta Lila Howard Foundation. He has received honoraria from Britannia, Roche, Novartis, Boehringer Ingelheim, Lundbeck, GE Healthcare, Servier, Teva, Solvay, GSK, Ipsen, Allergan, Orion, Bial, and AbbVie Lucid.
Start date: March 27, 2015
Expiration date: March 27, 2016
 

Vol 29.14: Neuropathology of Multiple System Atrophy: New Thoughts About Pathogenesis
Kurt A. Jellinger, MD
Author Disclosures: Kurt A. Jellinger, MD has received grants/research support from tbe Society for Supporting Research in Experimental Neurology, Vienna, Austria.
Start date: March 27, 2015
Expiration date: March 27, 2016
 

Vol 29.13: 7 Tesla Magnetic Resonance Imaging: A Closer Look at Substantia Nigra Anatomy in Parkinson’s Disease
Stephane Lehericy, MD, PhD; Eric Bardinet, PhD; Cyril Poupon, PhD; Marie Vidailhet, MD; and Chantal Francois, PhD
Author Disclosures: The five authors had no relevant financial information to disclose.
Start date: 3 February 2015
Expiration date: 3 February 2016


Vol 29.12: From Micrographia to Parkinson’s Disease Dysgraphia
Alban Letanneux, MSc; Jeremy Danna, PhD; Jean-Luc Velay, PhD; Francois Viallet, MD, PhD; and Serge Pinto, PhD
Author Disclosures: Alban Letanneux is employed by the French Research and Education Ministry. Jeremy Danna has received a post-doctorate grant from the French Labex BLRI (ANR-11-LABX-0036). Jean-Luc Velay his employed by the the French National Centre for Scientific Research. François Viallet, MD, PhD has received research support from Association France Parkinson and is employed by the National Hospital. Serge Pinto, PhD has received research support from Association France Parkinson and is employed by the French National Centre for Scientific Research.
Start date: 3 February 2015
Expiration date: 3 February 2016
 

Vol 29.11: Current Therapeutic Options for Huntington’s Disease: Good Clinical Practice Versus Evidence-Based Approaches?
Annie Killoran and Kevin M. Biglan
Author Disclosures: Annie Killoran, MD reports no financial disclosures. Kevin Biglan, MD, MPH has received funding from Lundbeck, HDSA,and PCORI. He has served as a consultant for Lundbeck, KJT consulting, Psyadom Pharmaceuticals, Inc.
Start date: 3 February 2015
Expiration date: 3 February 2016
 

Vol 29.10: From Yeast to Patient Neurons and Back Again: A Powerful New Discovery Platform
Daniel F. Tardiff, PhD; Vikram Khurana, MD; PhD,Chee Yeun Chung, PhD; and Susan Lindquist, PhD
Author Disclosures: The four authors had no relevant financial information to disclose.
Start date: 3 February 2015
Expiration date: 3 February 2016
 

Vol 29.9: Paroxysmal Dyskinesias Revisited: A Review of 500 Genetically Proven Cases and a New Classification
Kailash Bhatia, MD, DM, FRCP;  Roberto Erro, MD; Una-Marie Sheerin, MRCP
Author Disclosures: Prof. Kailash Bhatia, MD, DM, FRCP serves on the editorial boards of Movement Disorders and Therapeutic Advances in Neurological Disorders; receives royalties for the publication of Oxford Specialist Handbook of Parkinson's Disease and Other Movement Disorders (Oxford University Press, 2008) and Marsden's Book of Movement Disorders (Oxford University Press, 2012); has received funding for travel from GlaxoSmithKline, Orion Corporation, Ipsen, and Merz Pharmaceuticals, LLC; has received speaker honoraria from GlaxoSmithKline, Ipsen, Merz Pharmaceuticals, LLC, and Sun Pharmaceutical Industries Ltd.; has received personal compensation for serving on the scientific advisory boards of GSK and Boehringer Ingelheim; has received research support from Ipsen and the Halley Stewart Trust through Dystonia Society UK, and the Wellcome Trust MRC strategic neurodegenerative disease initiative award (Ref. number WT089698), and has received a grant from Parkinson's UK (Ref. number G-1009) and a grant from the Dystonia Coalition. Dr. Roberto Erro, MD and Dr. Una-Marie Sheerin, MRCP report no financial disclosures.
Start date: 13 October 2014
Expiration date: 13 October 2015
 

Vol 29.8: The Clinical Spectrum of Anxiety in Parkinson’s disease
Nadeeka Dissanayaka, BSc (Hons I), PhD;  Elizabeth White; John O'Sullivan, MBBS, MD; Rodney Marsh,
MBBS FRANZCP; Nancy Pachana, PhD;  Gerald J. Byrne, BSc (Med), MBBS (Hons), PhD, FRANZCP

Author Disclosures: Dr. Nadeeka Dissanayaka, BSc (Hons I), PhD is employed by the University of Queensland and has partnerships with Royal Brisbane & Women’s Hospital (honorary appointment, in-kind support). She has received a grant in 2014 from Royal Brisbane & Women’s Hospital ("Developing a non-invasive composite measure to enhance accuracy of identifying anxiety in Parkinson’s disease", awarded to N. Dissanayaka, G. Byrne, J, O’Sullivan, P. Silburn, R. Marsh, D. Copland, A. Angwin, G. Mellick, M. Breakspear , M. Garrido). She has received a grant for 2013-2016 from Lions Medical Research Fellowship 2013("New methods to diagnose and treat depression and anxiety in Parkinson’s disease patients", awarded to N. Dissanayaka). She has received a grant for 2013-2014 from RBWH Foundation ("Characterising anxiety in Parkinson’s disease: a psycholinguistic and psychophysiology study comparing to anxious older adults", awarded to N. Dissanayaka, G. Byrne, J. O'Sullivan, P. Silburn, R. Marsh, D. Copland, A. Angwin, G. Mellick). She has received a grant for 2013 from RBWH Foundation ("The effects of a wearable, freeze detecting cueing device and venlafaxine on domiciliary freezing of gait and falling in Parkinson’s Disease", awarded to R. Marsh, M. Cole, N. Dissanayaka, P. Silburn, J. O'Sullivan). She has received a grant for 2012-2013 from Parkinson’s Queensland Inc (PQI) Seeding Grant Scheme ("Cognitive sequelae in Parkinson’s disease: Identifying the neural substrates", awarded to A. Angwin, D. Copland, K, McMahon, N. Dissanayaka, P. Silburn). She has received a grant for 2011-2013 from RBWH Foundation (Improving diagnostic methods of anxiety disorders in Parkinson’s disease", awarded to N. Dissanayaka, J. O'Sullivan, P. Silburn, G. Byrne, D. Copland, G. Mellick, R. Marsh); and has received a grant for 2011-2013 from Parkinson’s Queensland Inc (PQI) Seeding Grant Scheme ("Novel methods for early detection of anxiety in Parkinson’s disease", awarded to N. Dissanayaka, P. Silburn, J. O'Sullivan, D. Copland,G. Mellick, R. Marsh).

Elizabeth White is employed by the University of Queensland as a research assistant, and has received a 2013-2014 grant from the University of Queensland, UQ Centre for a Clinical Research Summer Vacation Scholarship.

Dr. John O'Sullivan, MBBS, MD is employed by Royal Brisbane &Women’s Hospital / Queensland Health. He has served as a consultant for Allergan and Ipsen and has served on the advisory boards of AbbVie, Allergan, and Hospira. He has received honoraria/contracts from AbbVie, Allergan, Lunbeck, Ipsen and Novartis; and has received grants from the Brain Foundation and Royal Brisbane & Women’s Hospital Foundation.

Dr. Rodney Marsh, MBBS FRANZCP is employed by Royal Brisbane &Women’s Hospital / Queensland Health, and Neuroscience Queensland; has received honoraria from Servia, and has received a grant for 2013-2014 from RBWH Foundation ("The effects of a wearable, freeze detecting cueing device and venlafaxine on domiciliary freezing of gait and falling in Parkinson’s Disease", awarded to R. Marsh, M. Cole, N. Dissanayaka, P. Silburn, and J. O'Sullivan).

Prof. Nancy Pachana, PhD is employed by the University of Queensland; has served as a consultant for Alzheimer's Australia and QLD; and has received a grant from the National Health and Medical Research Council ("Centre of Excellence Award").

Prof. Gerald J. Byrne, BSc (Med), MBBS (Hons), PhD, FRANZCP is employed by the University of Queensland, School of Medicine as a salaried full professor, is employed as well by the Repatriation Medical Authority as a member receiving annual retainer plus sitting fees, is employed as well by Queensland Health as a consultant psychiatrist at the Royal Brisbane & Women’s Hospital, and also has a private practice for Geriatric Psychiatry and Forensic Psychiatry. He has a contract with TauRx for Leucomethylthioninium RCT for Alzheimer’s disease. He has received travel grants from TauRx and the International Psychogeriatric Association. He receives royalty payments for a published book: Byrne & Neville (2009) Community mental health for older people; and for a published rating scale :Geriatric Anxiety Inventory. He has stock ownership in CSL Behring (vaccines & blood products; annual dividends < $1,000 last 2 years) and YM Biosciences (hematology & cancer products; no dividends to date). He has copyright over the following rating scales: Geriatric Anxiety Inventory, Geriatric Anxiety Inventory – Research Form, Geriatric Anxiety Inventory – Short Form, and Informant Questionnaire for Anxiety in Dementia. He has copyright over the three following books: Fitzgerald J, Byrne GJ (2014) Psychosocial Dimensions of Medicine; Byrne GJ, Neville C. (2009) Community mental health for older people; and Sanders M, Mitchell C, Byrne GJ. (1997) Medical consultation skills - a practical handbook. He has received the following grants from the Australian National Health & Medical Research Council: "Kava for the treatment of generalized anxiety disorder: a 16-week double-blind RCT" (awarded to Sarris, Stough, Byrne, Scholey, Bousman); "The efficacy of adjunctive S-Adenosyl Methionine (SAMe) versus a combination nutraceutical in clinical depression: A double-blind, randomised, placebo-controlled trial" (awarded to Sarris, Schweitzer, Stough, Bousman, Byrne), "Randomised controlled trial of analgesic medications to modify behavioural and psychological symptoms of dementia" (awarded to Ames, Gibson, Byrne, Katz). He has received the following grant for 2011-2013 from Australian Dementia Collaborative Research Centres: "Improving anxiety assessment and management in people with dementia" (awarded to Byrne, Pachana, Beattie).
Start date: 13 October 2014
Expiration date: 13 October 2015
 

Vol. 29.7: "Female Reproductive Factors, Menopausal Hormone Use, and Parkinson’s Disease"
Rui Liu, PhD, Donna Baird, PhD, Yikyung Park, ScD, Neal D. Freedman, PhD, Xuemei Huang, MD, PhD, Albert
Hollenbeck, PhD, Aaron Blair, PhD, and Honglei Chen, MD, PhD

Author Disclosures: Rui Liu and Donna Baird are employed by the NIEHS, NIH. Xuemei Huang has served as a consultant for Navigant, US WorldMeds, and Solstice and receives research support from the NIH/NINDS (NS060722 [PI]). Albert R. Hollenbeck is a full-time employee of AARP on salary and has had no outside income in the last 24 months; he serves on two professional Boards that have no direct connection to the project; he is an elected Board Member of the Society of Psychologists in Management (no pay or reimbursements) and also serves on the Scientific Advisory Board of the Love/Avon Army of Women (no pay or reimbursements). Aaron Blair is a Scientist Emeritus at the National Cancer Institute and serves on the editorial advisory boards of the Scandinavian Journal of Work Environment and Health, the American Journal of Industrial Medicine, and the Journal of Agricultural Safety and Health and served as the Interim Director of the Occupational Cancer Research Centre in Toronto, Canada. Honglei Chen receives NIH intramural funding (Z01-ES-101986) and serves on the editorial boards of the American Journal of Epidemiology, International Journal of Molecular Epidemiology and Genetics, and American Journal of Neurodegenerative Disease. Neal D. Freedman and Yikyung Park report no disclosures.
Start Date: 14 July 2014
Expiration Date: 14 July 2015
 

Vol. 29.6: "The Clinical Spectrum of Laryngeal Dystonia Includes Dystonic Cough: Observations of a Large Series"
Susannah Payne, BA, BMed, MD, Stephen Tisch, MBBS, PhD, FRACP, Ian Cole, MBBS, FRCS, FRACS, MD,
Helen Brake, BA, BApplSc(SpPath), MCogSc, MBA, Judy Rough, BSpThy. Grad Dip Counselling. LMusA
(singing performance), and Paul Darveniza, MD, FRACP

Author Disclosures: S. Payne received a RAMUS scholarship for rural medical students. S. Tisch serves on the advisory boards of Apomorphine and Hospira Pharmaceuticals Australia, and he was sponsored by Novartis Pharmaceuticals to attend the Movement Disorder Society Meeting in Dublin in 2012. H. Brake is employed by St. Vincent's Hospital, Sydney (Manager, Speech Pathology Department) and Macquarie University (Lecturer in Voice Disorders and Laryngectomy). J. Rough is an employee of St. Vincent's Hospital and Macquarie University. S. Tisch, H. Brake, and J. Rough received a grant from St. Vincent's Clinic Foundation (a multi-disciplinary, patient-focused grant awarded in 2012 to J. Rough, S. Tisch, P. Fay, and H. Brake: “Improving the Delivery of Allied Health Services to Patients with Parkinson's Disease through TeleHealth”).
Start Date:  14 July 2014
Expiration Date: 14 July 2015

Top